Sera Prognostics, Inc. (SERA): Total Assets
$101.93M
As of 2025-12-31
$86.74M
As of 2026-06-30
-4.3%
3-year compound annual growth
+47.1%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $101.93M | +40.5% | 2026-03-18, Balance as of period end |
| 2024-12-31 | $72.58M | -24.0% | 2026-03-18, Balance as of period end |
| 2023-12-31 | $95.44M | -18.0% | 2025-03-19, Balance as of period end |
| 2022-12-31 | $116.33M | -20.9% | 2024-03-20, Balance as of period end |
| 2021-12-31 | $147.03M | +893.7% | 2023-03-22, Balance as of period end |
| 2020-12-31 | $14.80M | n/a | 2022-03-29, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Sera Prognostics, Inc. (SERA) | 2025-12-31 | $101.93M | +40.5% |
| Aclarion, Inc. (ACON) | 2025-12-31 | $13.67M | +543.9% |
| YD Bio Ltd (YDES) | 2025-12-31 | $13.78M | +100.7% |
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $9.25M | -11.3% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $55.48M | -7.8% |
| CapForce Inc. (CFOR) | 2025-12-31 | $38.06M | +285.8% |
| Exagen Inc. (XGN) | 2025-12-31 | $58.02M | +29.8% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $334.16M | +23.6% |
| Biodesix Inc (BDSX) | 2025-12-31 | $87.48M | -10.0% |
Compare SERA, ACON, YDES, BGLC side by side · Screen every company in Services-Medical Laboratories ↗